200 related articles for article (PubMed ID: 23334331)
1. EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF.
Gordon LK; Kiyohara M; Fu M; Braun J; Dhawan P; Chan A; Goodglick L; Wadehra M
Oncogene; 2013 Nov; 32(46):5369-76. PubMed ID: 23334331
[TBL] [Abstract][Full Text] [Related]
2. Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines.
Shimazaki K; Lepin EJ; Wei B; Nagy AK; Coulam CP; Mareninov S; Fu M; Wu AM; Marks JD; Braun J; Gordon LK; Wadehra M
Clin Cancer Res; 2008 Nov; 14(22):7367-77. PubMed ID: 19010852
[TBL] [Abstract][Full Text] [Related]
3. Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme.
Qin Y; Takahashi M; Sheets K; Soto H; Tsui J; Pelargos P; Antonios JP; Kasahara N; Yang I; Prins RM; Braun J; Gordon LK; Wadehra M
J Neurooncol; 2017 Aug; 134(1):29-40. PubMed ID: 28597184
[TBL] [Abstract][Full Text] [Related]
4. Epithelial membrane protein 2 (EMP2) regulates hypoxia-induced angiogenesis in the adult retinal pigment epithelial cell lines.
Sun M; Cherian N; Liu L; Chan AM; Aguirre B; Chu A; Strawbridge J; Kim ES; Lin MC; Tsui I; Gordon LK; Wadehra M
Sci Rep; 2022 Nov; 12(1):19432. PubMed ID: 36371458
[TBL] [Abstract][Full Text] [Related]
5. EMP2 is a novel therapeutic target for endometrial cancer stem cells.
Kiyohara MH; Dillard C; Tsui J; Kim SR; Lu J; Sachdev D; Goodglick L; Tong M; Torous VF; Aryasomayajula C; Wang W; Najafzadeh P; Gordon LK; Braun J; McDermott S; Wicha MS; Wadehra M
Oncogene; 2017 Oct; 36(42):5793-5807. PubMed ID: 28604744
[TBL] [Abstract][Full Text] [Related]
6. Epithelial membrane protein 2 controls VEGF expression in ARPE-19 cells.
Morales SA; Telander DG; Leon D; Forward K; Braun J; Wadehra M; Gordon LK
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2367-72. PubMed ID: 23439602
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments.
Fu M; Brewer S; Olafsen T; Wu AM; Gordon LK; Said J; Braun J; Wadehra M
Mol Imaging Biol; 2013 Feb; 15(1):68-78. PubMed ID: 22585360
[TBL] [Abstract][Full Text] [Related]
8. Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model.
Sun MM; Chan AM; Law SM; Duarte S; Diaz-Aguilar D; Wadehra M; Gordon LK
Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):245-254. PubMed ID: 30646013
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biological significance of vascular endothelial growth factor in endometrial cancer.
Kamat AA; Merritt WM; Coffey D; Lin YG; Patel PR; Broaddus R; Nugent E; Han LY; Landen CN; Spannuth WA; Lu C; Coleman RL; Gershenson DM; Sood AK
Clin Cancer Res; 2007 Dec; 13(24):7487-95. PubMed ID: 18094433
[TBL] [Abstract][Full Text] [Related]
10. Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome.
Wadehra M; Natarajan S; Seligson DB; Williams CJ; Hummer AJ; Hedvat C; Braun J; Soslow RA
Cancer; 2006 Jul; 107(1):90-8. PubMed ID: 16736513
[TBL] [Abstract][Full Text] [Related]
11. Epithelial membrane protein-2 promotes endometrial tumor formation through activation of FAK and Src.
Fu M; Rao R; Sudhakar D; Hogue CP; Rutta Z; Morales S; Gordon LK; Braun J; Goodglick L; Wadehra M
PLoS One; 2011; 6(5):e19945. PubMed ID: 21637765
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia contributes to development of recurrent endometrial carcinoma.
Pijnenborg JM; Wijnakker M; Hagelstein J; Delvoux B; Groothuis PG
Int J Gynecol Cancer; 2007; 17(4):897-904. PubMed ID: 17359291
[TBL] [Abstract][Full Text] [Related]
13. Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development.
Habeeb O; Goodglick L; Soslow RA; Rao RG; Gordon LK; Schirripa O; Horvath S; Braun J; Seligson DB; Wadehra M
Cancer; 2010 Oct; 116(20):4718-26. PubMed ID: 20578181
[TBL] [Abstract][Full Text] [Related]
14. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
15. Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.
Fu M; Maresh EL; Soslow RA; Alavi M; Mah V; Zhou Q; Iasonos A; Goodglick L; Gordon LK; Braun J; Wadehra M
Clin Cancer Res; 2010 Aug; 16(15):3954-63. PubMed ID: 20670949
[TBL] [Abstract][Full Text] [Related]
16. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
17. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
18. Sex steroid-dependent angiogenesis in uterine endometrial cancers.
Fujimoto J; Toyoki H; Jahan I; Alam SM; Sakaguchi H; Sato E; Tamaya T
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):161-5. PubMed ID: 15860258
[TBL] [Abstract][Full Text] [Related]
19. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
20. Epithelial membrane protein 2 (EMP2) deficiency alters placental angiogenesis, mimicking features of human placental insufficiency.
Williams CJ; Chu A; Jefferson WN; Casero D; Sudhakar D; Khurana N; Hogue CP; Aryasomayajula C; Patel P; Sullivan P; Padilla-Banks E; Mohandessi S; Janzen C; Wadehra M
J Pathol; 2017 Jun; 242(2):246-259. PubMed ID: 28295343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]